SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001842952-23-000046
Filing Date
2023-03-27
Accepted
2023-03-27 16:02:59
Documents
4
Period of Report
2023-05-31

Document Format Files

Seq Description Document Type Size
1 PRE 14A contexttherapeutics2023pro.htm PRE 14A 464759
2 contexttherapeuticsinc_vxp.jpg GRAPHIC 438824
3 contexttherapeuticsinc_vxpa.jpg GRAPHIC 196188
4 downloada.jpg GRAPHIC 12205
  Complete submission text file 0001842952-23-000046.txt   1356915
Mailing Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103
Business Address 2001 MARKET STREET SUITE 3915 UNIT #15 PHILADELPHIA PA 19103 267-225-7416
Context Therapeutics Inc. (Filer) CIK: 0001842952 (see all company filings)

IRS No.: 863738787 | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-40654 | Film No.: 23764524
SIC: 2834 Pharmaceutical Preparations